Warning: The NCBI web site requires JavaScript to function. more...
Ku proteins interact with activator protein-2 transcription factors and contribute to ERBB2 overexpression in breast cancer cell lines.
Nolens G, Pignon JC, Koopmansch B, Elmoualij B, Zorzi W, De Pauw E, Winkler R.
Breast Cancer Res. 2009;11(6):R83. Epub 2009 Nov 11.
Related citations
Yin Yang 1 cooperates with activator protein 2 to stimulate ERBB2 gene expression in mammary cancer cells.
Begon DY, Delacroix L, Vernimmen D, Jackers P, Winkler R.
J Biol Chem. 2005 Jul 1;280(26):24428-34. Epub 2005 May 3.
The combined immunodetection of AP-2alpha and YY1 transcription factors is associated with ERBB2 gene overexpression in primary breast tumors.
Allouche A, Nolens G, Tancredi A, Delacroix L, Mardaga J, Fridman V, Winkler R, Boniver J, Delvenne P, Begon DY.
Breast Cancer Res. 2008;10(1):R9. Epub 2008 Jan 24.
Distal ERBB2 promoter fragment displays specific transcriptional and nuclear binding activities in ERBB2 overexpressing breast cancer cells.
Delacroix L, Begon D, Chatel G, Jackers P, Winkler R.
DNA Cell Biol. 2005 Sep;24(9):582-94.
Differential regulation of ErbB2 expression by cAMP-dependent protein kinase in tamoxifen-resistant breast cancer cells.
Yang JW, Kim MR, Kim HG, Kim SK, Jeong HG, Kang KW.
Arch Pharm Res. 2008 Mar;31(3):350-6. Epub 2008 Apr 13.
Activator protein-2gamma (AP-2gamma) expression is specifically induced by oestrogens through binding of the oestrogen receptor to a canonical element within the 5'-untranslated region.
Orso F, Cottone E, Hasleton MD, Ibbitt JC, Sismondi P, Hurst HC, De Bortoli M.
Biochem J. 2004 Jan 15;377(Pt 2):429-38.
Regulation of KiSS-1 metastasis suppressor gene expression in breast cancer cells by direct interaction of transcription factors activator protein-2alpha and specificity protein-1.
Mitchell DC, Abdelrahim M, Weng J, Stafford LJ, Safe S, Bar-Eli M, Liu M.
J Biol Chem. 2006 Jan 6;281(1):51-8. Epub 2005 Oct 27.
AP-2alpha and AP-2gamma are transcriptional targets of p53 in human breast carcinoma cells.
Li H, Watts GS, Oshiro MM, Futscher BW, Domann FE.
Oncogene. 2006 Aug 31;25(39):5405-15. Epub 2006 Apr 24.
Ku is a novel transcriptional recycling coactivator of the androgen receptor in prostate cancer cells.
Mayeur GL, Kung WJ, Martinez A, Izumiya C, Chen DJ, Kung HJ.
J Biol Chem. 2005 Mar 18;280(11):10827-33. Epub 2005 Jan 7.
Expression of AP-2 transcription factors in human breast cancer correlates with the regulation of multiple growth factor signalling pathways.
Turner BC, Zhang J, Gumbs AA, Maher MG, Kaplan L, Carter D, Glazer PM, Hurst HC, Haffty BG, Williams T.
Cancer Res. 1998 Dec 1;58(23):5466-72.
Different mechanisms are implicated in ERBB2 gene overexpression in breast and in other cancers.
Vernimmen D, Gueders M, Pisvin S, Delvenne P, Winkler R.
Br J Cancer. 2003 Sep 1;89(5):899-906.
Transcriptional factor AP-2gamma increases human cystatin A gene transcription of keratinocytes.
Takahashi H, Oyama N, Itoh Y, Ishida-Yamamoto A, Kaneko F, Iizuka H.
Biochem Biophys Res Commun. 2000 Nov 30;278(3):719-23.
Bifunctional effect of resveratrol on the expression of ErbB2 in human breast cancer cell.
Choi HK, Yang JW, Kang KW.
Cancer Lett. 2006 Oct 28;242(2):198-206. Epub 2006 Feb 20.
AP-2 regulates the transcription of estrogen receptor (ER)-beta by acting through a methylation hotspot of the 0N promoter in prostate cancer cells.
Zhang X, Leung YK, Ho SM.
Oncogene. 2007 Nov 15;26(52):7346-54. Epub 2007 May 21.
Identification of target genes of transcription factor activator protein 2 gamma in breast cancer cells.
Ailan H, Xiangwen X, Daolong R, Lu G, Xiaofeng D, Xi Q, Xingwang H, Rushi L, Jian Z, Shuanglin X.
BMC Cancer. 2009 Aug 11;9:279.
Inefficient proteasomal-degradation pathway stabilizes AP-2alpha and activates HER-2/neu gene in breast cancer.
Li M, Wang Y, Hung MC, Kannan P.
Int J Cancer. 2006 Feb 15;118(4):802-11.
Identification of HTF (HER2 transcription factor) as an AP-2 (activator protein-2) transcription factor and contribution of the HTF binding site to ERBB2 gene overexpression.
Vernimmen D, Begon D, Salvador C, Gofflot S, Grooteclaes M, Winkler R.
Biochem J. 2003 Feb 15;370(Pt 1):323-9.
Ku protein targeting by Ku70 small interfering RNA enhances human cancer cell response to topoisomerase II inhibitor and gamma radiation.
Ayene IS, Ford LP, Koch CJ.
Mol Cancer Ther. 2005 Apr;4(4):529-36.
A negative feedback regulatory loop associates the tyrosine kinase receptor ERBB2 and the transcription factor GATA4 in breast cancer cells.
Hua G, Zhu B, Rosa F, Deblon N, Adélaïde J, Kahn-Perlès B, Birnbaum D, Imbert J.
Mol Cancer Res. 2009 Mar;7(3):402-14. Epub 2009 Mar 10.
Re-expression of SPR1 in breast cancer cells by phorbol 12-myristate 13-acetate (PMA) or UV irradiation is mediated by the AP-1 binding site in the SPR1 promoter.
Anisowicz A, Sotiropoulou G, Sager R.
Mol Med. 1999 Aug;5(8):526-41.
Filter your results:
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on